The Annual Meeting is one of the world’s leading forums for the exchange of cutting edge scientific information about the brain, behavior, and psychotropic drugs. The Annual Meeting provides an opportunity to: • Attend an outstanding scientific program in clinical and basic research on brain behavior-drug interactions. • Learn about the most recent and often [...]
As the largest gathering on epilepsy in the world, the American Epilepsy Society's Annual Meeting is the event for epilepsy professionals in academia, clinical practice, industry, and advocacy. Stay tuned for details on AES 2020 in Seattle.
The scarcity of new drugs for neuropsychiatric disorders contrasts with the extraordinary advances in neuroscience research to date. Focusing from bench to bedside, and built with thought-leaders at Sage Therapeutics, Janssen, Lundbeck and Roche, the 3rd Annual Neuropsychiatric Drug Development Summit will unravel the complexities of developing truly clinically transformative neuropsychiatric drugs. With an emphasis [...]
Join the pharma and biotech R&D leaders, the top tech companies involved in clinical development and healthcare innovation, investigator sites, service companies, and the regulators from FDA and EMA at CNS Summit 2019. For three days, you’ll experience a dynamic environment for networking and idea-sharing, for learning from industry leaders and exploring the future [...]
SLEEP is the premier world forum for the presentation and discussion of the latest developments in clinical sleep medicine and sleep and circadian science. The SLEEP meeting provides evidence-based education to advance the science and clinical practice of sleep medicine, disseminates cutting-edge sleep and circadian research, promotes the translation of basic science into clinical practice, [...]
Recent years have seen a steady increase in the new applications of somatic therapies that target symptom change in interaction with psychotherapeutic interventions. Examples range from use of repetitive transcranial magnetic stimulation combined with symptom provocation for obsessive compulsive disorder, to intranasal oxytocin combined with social cognition training for young people with early psychosis, to [...]
The 2020 ASCP Annual Meeting will be held in Miami Beach, Florida from May 26 - 29, 2020. The meeting includes representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry that will discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes [...]
The leading Outsourcing conference series returns to San Diego for its 7th year in September 2019. With a focus on providing delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials, this is an event not to be missed. Not only will the audience be discussing ever-pressing partnership and [...]
Exhibit Booth #2 The American Society for Clinical Pharmacology and Therapeutics will bring together around 1,400 clinical pharmacologists, translational scientists, and educators to share research, knowledge, and experiences. State of the Art Lectures, which will present the “From Molecule to Patient” theme from various perspectives, including Pharma, Biotech, and Global Health; Innovation Forum, an interactive [...]
The 7th World CNS Summit is the only industry-specific conference exclusively focused on advancing translational neurodegenerative research. World CNS’s mission is to reinvigorate drug discovery and development across multiple neurodegenerative disorders by providing an interactive environment that ensures thought-provoking discussions and unparalleled networking opportunities for all of our attendees, helping to overcome the translational challenges in developing efficacious therapeutics. Developed in combination with experts from Biogen, Eisai, Merck, AbbVie and other leading organizations, the World CNS Summit uniquely combines distinct neurodegenerative diseases in one setting to examine mechanisms of disease and emerging strategies for targeting.